---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-223967"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2026-05-14T20:04:49+00:00"
generated_at: "2026-05-14T21:02:04.596714+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CV Sciences Q1 revenue down 11.4% to $3.2M; adjusted EBITDA loss narrows to $0.1M

## Summary
- Revenue $3.2M (down 11.4% YoY); unit sales down 12.2%, partially offset by minor price increases.
- Gross margin improved to 48.9% (from 46.0% YoY); operating loss $0.3M vs prior year operating income due to $0.5M payroll tax reversal.
- Adjusted EBITDA loss of $0.1M vs $0.3M loss in Q1 2025; cash balance $0.3M at quarter end.
- Completed debt restructuring to strengthen financial position; launched EMPOWR plant-based protein/creatine formula.
- New products launched since Jan 2023 contributed 43% of Q1 net revenue; 45 new products introduced.

## SEC filing metadata
- accession: 0001193125-26-223967
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2026-05-14T20:04:49+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000119312526223967/0001193125-26-223967-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000119312526223967/cvsi-20260514.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-223967
- JSON: https://secwatch.observer/filing/0001193125-26-223967.json
- Plain text: https://secwatch.observer/filing/0001193125-26-223967.txt

## Key facts
- Earnings Releases
  CV Sciences, Inc. reported the quarter ended March 31, 2026 results: revenue $3.2 million.
  - Period: the quarter ended March 31, 2026
  - Revenue: $3.2 million
  - Result: reported results
  source text: Generated revenue of $3.2 million for the first quarter 2026 compared to $3.6 million for the first quarter 2025
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526223967/0001193125-26-223967-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.